Peggy N. Atmodimedjo

The impact of surgery in molecularly defined low-grade glioma: an integrated clinical, radiological, and molecular analysis

Maarten M.J. Wijnenga, Pim J. French, Hendrikus J. Dubbink et al. · Neuro-Oncology · 2017 · 331 citations · Full text

Medicine, Oncology, Surgery +17

Survival of diffuse astrocytic glioma, IDH1/2 wildtype, with molecular features of glioblastoma, WHO grade IV: a confirmation of the cIMPACT-NOW criteria

C. Mircea S. Tesileanu, Linda Dirven, Maarten M.J. Wijnenga et al. · Neuro-Oncology · 2019 · 215 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial

Hendrikus J. Dubbink, Peggy N. Atmodimedjo, Johan M. Kros et al. · Neuro-Oncology · 2015 · 162 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Diagnostic Detection of Allelic Losses and Imbalances by Next-Generation Sequencing

Hendrikus J. Dubbink, Peggy N. Atmodimedjo, Ronald van Marion et al. · Journal of Molecular Diagnostics · 2016 · 74 citations

Life Sciences, Genetics, Molecular Genetics +16

Temozolomide and Radiotherapy versus Radiotherapy Alone in Patients with Glioblastoma, <i>IDH</i> -wildtype: <i>Post Hoc</i> Analysis of the EORTC Randomized Phase III CATNON Trial

C. Mircea S. Tesileanu, Marc Sanson, Wolfgang Wick et al. · Clinical Cancer Research · 2022 · 72 citations · Full text

Medicine, Oncology, Radiation Oncology +17